Stock image for illustration purposes only - book cover, edition or condition may vary.
Proteasome Inhibitors in Cancer Therapy
Julian . Ed(S): Adams
€ 187.73
FREE Delivery in Ireland
Description for Proteasome Inhibitors in Cancer Therapy
Paperback. Takes stock of the work that has been accomplished with proteasome inhibitors in cancer, and examines various therapeutic possibilities. This title covers topics ranging from a discussion of the chemistry and cell biology of the proteasome and the rationale for proteasome inhibitors in cancer to a review of clinical trials underway. Editor(s): Adams, Julian. Series: Cancer Drug Discovery and Development. Num Pages: 313 pages, biography. BIC Classification: MQP. Category: (P) Professional & Vocational. Dimension: 254 x 178 x 17. Weight in Grams: 578.
A panel of leading academic and pharmaceutical investigators takes stock of the remarkable work that has been accomplished to date with proteasome inhibitors in cancer, and examines emerging therapeutic possibilities. The topics range from a discussion of the chemistry and cell biology of the proteasome and the rationale for proteasome inhibitors in cancer to a review of current clinical trials underway. The discussion of rationales for testing proteasome inhibitors in cancer models covers the role of the proteasome in NF-kB activation, the combining of conventional chemotherapy and radiation with proteasome inhibition, notably PS-341, new proteasome methods of inhibiting viral maturation, ... Read more
A panel of leading academic and pharmaceutical investigators takes stock of the remarkable work that has been accomplished to date with proteasome inhibitors in cancer, and examines emerging therapeutic possibilities. The topics range from a discussion of the chemistry and cell biology of the proteasome and the rationale for proteasome inhibitors in cancer to a review of current clinical trials underway. The discussion of rationales for testing proteasome inhibitors in cancer models covers the role of the proteasome in NF-kB activation, the combining of conventional chemotherapy and radiation with proteasome inhibition, notably PS-341, new proteasome methods of inhibiting viral maturation, ... Read more
Product Details
Format
Paperback
Publication date
2010
Publisher
Humana Press Inc. United States
Number of pages
313
Condition
New
Series
Cancer Drug Discovery and Development
Number of Pages
313
Place of Publication
Totowa, NJ, United States
ISBN
9781617374524
SKU
V9781617374524
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for Proteasome Inhibitors in Cancer Therapy
"Authoritative and illuminating...." - Tumori